Market Value1,459,844,394
Total Holdings67
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NTRA / Natera, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
EOLS / Evolus, Inc.
AFMD / Affimed N.V.
BHVN / Biohaven Ltd.
HQY / HealthEquity, Inc.
STOK / Stoke Therapeutics, Inc.
ACIU / AC Immune SA
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
FULC / Fulcrum Therapeutics, Inc.
OSCR / Oscar Health, Inc.
MYGN / Myriad Genetics, Inc.
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
LLY / Eli Lilly and Company
CYTK / Cytokinetics, Incorporated
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
CERE / Cerevel Therapeutics Holdings, Inc.
GTHX / G1 Therapeutics, Inc.
MLTX / MoonLake Immunotherapeutics
BKD / Brookdale Senior Living Inc.
NVRO / Nevro Corp.
TERN / Terns Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
MCRB / Seres Therapeutics, Inc.
XOMA / XOMA Royalty Corporation
STRO / Sutro Biopharma, Inc.
ABSI / Absci Corporation
IFRX / InflaRx N.V.
VKTX / Viking Therapeutics, Inc.
TRML / Tourmaline Bio, Inc.
FNA / Paragon 28, Inc.
ITCI / Intra-Cellular Therapies, Inc.
KURA / Kura Oncology, Inc.
AVTE / Aerovate Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
RGEN / Repligen Corporation
CLDX / Celldex Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
IONS / Ionis Pharmaceuticals, Inc.
MRUS / Merus N.V.
AVTR / Avantor, Inc.
PCVX / Vaxcyte, Inc.
FTRE / Fortrea Holdings Inc.
HUM / Humana Inc.
TSVT / 2seventy bio, Inc.
KPTI / Karyopharm Therapeutics Inc.
GH / Guardant Health, Inc.
IQV / IQVIA Holdings Inc.
HCA / HCA Healthcare, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
MNKD / MannKind Corporation
PTGX / Protagonist Therapeutics, Inc.
ALEC / Alector, Inc.
ZBIO / Zenas BioPharma, Inc.
INSP / Inspire Medical Systems, Inc.
TECH / Bio-Techne Corporation
LQDA / Liquidia Corporation
RVTY / Revvity, Inc.
ZIMV / ZimVie Inc.
PBYI / Puma Biotechnology, Inc.
VERA / Vera Therapeutics, Inc.
CNC / Centene Corporation
VRDN / Viridian Therapeutics, Inc.
MOH / Molina Healthcare, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
ICLR / ICON Public Limited Company
GOSS / Gossamer Bio, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
ELV / Elevance Health, Inc.
CYH / Community Health Systems, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
SPY / SPDR S&P 500 ETF Put
TVTX / Travere Therapeutics, Inc.
INSM / Insmed Incorporated
UTHR / United Therapeutics Corporation
VTRS / Viatris Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
DHR / Danaher Corporation
BHC / Bausch Health Companies Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
GSK / GSK plc - Depositary Receipt (Common Stock)
STAA / STAAR Surgical Company